A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study

NCT05095571 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DIETARY_SUPPLEMENT: EH301 (Nicotinamide Riboside/Pterostilbene)

Sponsor

Haukeland University Hospital

Collaborators

[object Object]